Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordan Berlin

Showing results (61-70 of 148) with videos related to

Pageof 15
Sort By:
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
American Journal of Clinical Pathology|February 20, 2015
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsChanjuan Shi, Raul S Gonzalez, Zhiguo Zhao, et al.
Clinical Colorectal Cancer|April 22, 2022
Safety and Efficacy of Avelumab in Small Bowel AdenocarcinomaDana B Cardin, Jill Gilbert, Jennifer G Whisenant, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2023
Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysisSatya Das, Sharon Phillips, Cody L Lee, et al.
Cancers|February 11, 2023
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational StudyR Dixon Dorand, Neil S Zheng, Rajiv Agarwal, et al.
Investigational New Drugs|October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trialDana B Cardin, Laura W Goff, Emily Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
The Oncologist|September 4, 2009
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort studyMark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, et al.
Translational Oncology|July 12, 2020
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancerAllison S Cohen, Ling Geng, Ping Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 studyKenneth R Hande, Anne Hagey, Jordan Berlin, et al.
Pageof 15

Showing results (61-70 of 148) with videos related to

Sort By:
Pageof 15
Clinical Colorectal Cancer|July 16, 2008
Association of K-ras mutational status and clinical outcomes in patients with metastatic colorectal cancer receiving panitumumab aloneDaniel J Freeman, Todd Juan, Maureen Reiner, et al.
American Journal of Clinical Pathology|February 20, 2015
Liver metastases of small intestine neuroendocrine tumors: Ki-67 heterogeneity and World Health Organization grade discordance with primary tumorsChanjuan Shi, Raul S Gonzalez, Zhiguo Zhao, et al.
Clinical Colorectal Cancer|April 22, 2022
Safety and Efficacy of Avelumab in Small Bowel AdenocarcinomaDana B Cardin, Jill Gilbert, Jennifer G Whisenant, et al.
European Journal of Cancer (Oxford, England : 1990)|February 4, 2023
Efficacy and toxicity of anti-vascular endothelial growth receptor tyrosine kinase inhibitors in patients with neuroendocrine tumours - A systematic review and meta-analysisSatya Das, Sharon Phillips, Cody L Lee, et al.
Cancers|February 11, 2023
Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational StudyR Dixon Dorand, Neil S Zheng, Rajiv Agarwal, et al.
Investigational New Drugs|October 10, 2017
Dual Src and EGFR inhibition in combination with gemcitabine in advanced pancreatic cancer: phase I results : A phase I clinical trialDana B Cardin, Laura W Goff, Emily Chan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2009
Phase III, randomized study of gemcitabine and oxaliplatin versus gemcitabine (fixed-dose rate infusion) compared with gemcitabine (30-minute infusion) in patients with pancreatic carcinoma E6201: a trial of the Eastern Cooperative Oncology GroupElizabeth Poplin, Yang Feng, Jordan Berlin, et al.
The Oncologist|September 4, 2009
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort studyMark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, et al.
Translational Oncology|July 12, 2020
Combined blockade of EGFR and glutamine metabolism in preclinical models of colorectal cancerAllison S Cohen, Ling Geng, Ping Zhao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
The pharmacokinetics and safety of ABT-751, a novel, orally bioavailable sulfonamide antimitotic agent: results of a phase 1 studyKenneth R Hande, Anne Hagey, Jordan Berlin, et al.
Pageof 15